Ke P, Yeh C
Pathogens. 2024; 13(11).
PMID: 39599533
PMC: 11597459.
DOI: 10.3390/pathogens13110980.
Chuang Y, Ou J
Microbiol Mol Biol Rev. 2024; 88(4):e0001424.
PMID: 39440957
PMC: 11653734.
DOI: 10.1128/mmbr.00014-24.
Tan X, Xiang Y, Shi J, Chen L, Yu D
J Pharm Anal. 2024; 14(9):100979.
PMID: 39310850
PMC: 11415714.
DOI: 10.1016/j.jpha.2024.100979.
Seurre C, Roca Suarez A, Testoni B, Zoulim F, Grigorov B
Int J Mol Sci. 2024; 25(13).
PMID: 39000179
PMC: 11241208.
DOI: 10.3390/ijms25137073.
Liu X, Xu J, Zhang M, Wang H, Guo X, Zhao M
J Virol. 2024; 98(7):e0060624.
PMID: 38809020
PMC: 11264595.
DOI: 10.1128/jvi.00606-24.
CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells.
Bunz M, Eisele M, Hu D, Ritter M, Kammerloher J, Lampl S
Front Cell Infect Microbiol. 2024; 14:1338606.
PMID: 38357447
PMC: 10864554.
DOI: 10.3389/fcimb.2024.1338606.
Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids.
So C, Sourisseau M, Sarwar S, Evans M, Randall G
PLoS Pathog. 2023; 19(12):e1011887.
PMID: 38157366
PMC: 10756512.
DOI: 10.1371/journal.ppat.1011887.
The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity.
Carriqui-Madronal B, Sheldon J, Duven M, Stegmann C, Cirksena K, Wyler E
PLoS Pathog. 2023; 19(11):e1011759.
PMID: 37967063
PMC: 10650992.
DOI: 10.1371/journal.ppat.1011759.
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities.
Chowdhary S, Deka R, Panda K, Kumar R, Solomon A, Das J
Mol Pharm. 2023; 20(8):3698-3740.
PMID: 37486263
PMC: 10410670.
DOI: 10.1021/acs.molpharmaceut.2c01080.
Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection.
Ibrahim Salama I, Raslan H, Abdel-Latif G, Salama S, Sami S, Shaaban F
World J Hepatol. 2022; 14(6):1053-1073.
PMID: 35978668
PMC: 9258264.
DOI: 10.4254/wjh.v14.i6.1053.
Differential expression profile and in-silico functional analysis of long noncoding RNA and mRNA in duck embryo fibroblasts infected with duck plague virus.
Wu Z, Zeng Y, Cheng A, Sun A, Wang M, Chen S
BMC Genomics. 2022; 23(1):509.
PMID: 35836133
PMC: 9281093.
DOI: 10.1186/s12864-022-08739-7.
Natural flavonoids effectively block the CD81 receptor of hepatocytes and inhibit HCV infection: a computational drug development approach.
Dey D, Biswas P, Paul P, Mahmud S, Ema T, Khan A
Mol Divers. 2022; 27(3):1309-1322.
PMID: 35821161
DOI: 10.1007/s11030-022-10491-9.
Entry Inhibitors of Hepatitis C Virus.
Qian X, Qi Z
Adv Exp Med Biol. 2022; 1366:207-222.
PMID: 35412143
DOI: 10.1007/978-981-16-8702-0_13.
Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences.
Boulahtouf Z, Virzi A, Baumert T, Verrier E, Lupberger J
Int J Mol Sci. 2022; 23(5).
PMID: 35269929
PMC: 8911453.
DOI: 10.3390/ijms23052787.
Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools.
Sabariegos R, Ortega-Prieto A, Diaz-Martinez L, Grande-Perez A, Garcia Crespo C, Gallego I
PLoS Pathog. 2022; 18(1):e1010210.
PMID: 35085375
PMC: 8794218.
DOI: 10.1371/journal.ppat.1010210.
HCV Reporter System (Viral Infection-Activated Split-Intein-Mediated Reporter System) for Testing Virus Cell-to-cell Transmission .
Zhao F, Zhao T, Deng L, Lv D, Zhang X, Pan X
Bio Protoc. 2021; 8(15):e2949.
PMID: 34395761
PMC: 8328627.
DOI: 10.21769/BioProtoc.2949.
Cellular factors involved in the hepatitis C virus life cycle.
Li H, Yang C, Lo S
World J Gastroenterol. 2021; 27(28):4555-4581.
PMID: 34366623
PMC: 8326260.
DOI: 10.3748/wjg.v27.i28.4555.
Hepatitis C Virus Uses Host Lipids to Its Own Advantage.
Sidorkiewicz M
Metabolites. 2021; 11(5).
PMID: 33925362
PMC: 8145847.
DOI: 10.3390/metabo11050273.
Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development.
Virzi A, Gonzalez-Motos V, Tripon S, Baumert T, Lupberger J
J Clin Med. 2021; 10(5).
PMID: 33801181
PMC: 7957739.
DOI: 10.3390/jcm10050977.
Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus.
Ghildiyal R, Gabrani R
Virusdisease. 2021; 32(1):55-64.
PMID: 33723515
PMC: 7945596.
DOI: 10.1007/s13337-021-00665-8.